Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hajage

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Brain : a Journal of Neurology|December 12, 2017
Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5Cecilia Marelli, Foudil Lamari, Dominique Rainteau, et al.
Trials|April 24, 2015
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI)Stéphane Gaudry, David Hajage, Fréderique Schortgen, et al.
The Lancet. Respiratory Medicine|January 14, 2023
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort studyMatthieu Schmidt, David Hajage, Micha Landoll, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2023
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in RemissionJoanna Kedra, Philippe Dieudé, Caroline Giboin, et al.
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Brain : a Journal of Neurology|December 12, 2017
Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5Cecilia Marelli, Foudil Lamari, Dominique Rainteau, et al.
Trials|April 24, 2015
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI)Stéphane Gaudry, David Hajage, Fréderique Schortgen, et al.
The Lancet. Respiratory Medicine|January 14, 2023
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort studyMatthieu Schmidt, David Hajage, Micha Landoll, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2023
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in RemissionJoanna Kedra, Philippe Dieudé, Caroline Giboin, et al.
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Pageof 14